Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic Cancer

Rexin-G is a pathotropic retroviral vector displaying a von Willebrand factor–targeting motif and expressing a dominant negative cyclin G1 gene. We undertook a phase I trial of intravenous (IV) administration of Rexin-G in patients with gemcitabine refractory, metastatic pancreatic adenocarcinoma. T...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Galanis, Evanthia, Carlson, Stephanie K, Foster, Nathan R, Lowe, Val, Quevedo, Fernando, McWilliams, Robert R, Grothey, Axel, Jatoi, Aminah, Alberts, Steven R, Rubin, Joseph
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2756987/
https://ncbi.nlm.nih.gov/pubmed/18388964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2008.29
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak